Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients.
Woodman
Richard J
RJ
Mori
Trevor A
TA
Burke
Valerie
V
Puddey
Ian B
IB
Watts
Gerald F
GF
Best
James D
JD
Beilin
Lawrence J
LJ
D000328:Adult; D000368:Aged; D008078:Cholesterol, LDL / Q000097:blood* / Q000737:chemistry; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy*; D004281:Docosahexaenoic Acids / Q000627:therapeutic use*; D015118:Eicosapentaenoic Acid; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy; D006977:Hypertension, Renal / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010316:Particle Size
D008078:Cholesterol, LDL; D005231:Fatty Acids, Unsaturated; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid